Early in 2024, the American Academy of Orthopaedic Surgeons board of directors approved a new strategic plan, which included ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Epigenetic changes — particularly altered DNA methylation — at birth may be associated with risk for metabolic dysfunction ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...

Two-thirds of girls aged 13 to 17 years live in states with abortion bans, gestational limits or parental involvement laws, according to a study published in JAMA Pediatrics. Since the U.S. Supreme ...

In this Healio video, Edward L. Barnes, MD, MPH, associate professor of medicine, co-director of the Multidisciplinary IBD Center and associate fellowship program director at the University of North ...

Migrants traveling into the United States face a range of exposures and social factors that can adversely impact skin health, but the prevalence of specific dermatologic skin conditions remains poorly ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...

Increasing awareness of the looming threat to brain health posed by global climate change is key for neurologists, according ...

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

As former NCI Director W. Kimryn Rathmell, MD, PhD, MMHC, embarks on the next stage of her career as CEO of the James Cancer ...